Florida House Bill H1265

Florida 2023 Regular Session

• Introduced: 2/28/23
• Refer: 3/6/23
• Failed: 5/5/23

Caption

Employer Coverage of Gender Dysphoria Treatment

Impact

The implications of HB 1265 extend significantly into state law, reshaping the legal landscape regarding healthcare coverage for gender dysphoria. By mandating that employers not only provide initial treatment coverage but also cover any reversal treatments, the bill establishes a legal framework that can influence employer policies across Florida. This could lead to increased healthcare costs for employers, particularly in sectors that employ a diverse workforce, and may compel companies to reevaluate their benefits packages in light of these new requirements.

Summary

House Bill 1265, also known as the 'Reverse Woke Act,' seeks to establish mandates regarding employer coverage of treatment related to gender dysphoria. The bill requires that if an employer provides coverage for gender dysphoria treatment—such as surgeries or hormone therapies—they must also cover the full costs of any treatment that reverses such treatment. This stipulation applies regardless of the employee's current employment status with the employer, ensuring that former employees retain their right to coverage for reversal treatments should they determine the initial treatment was inappropriate.

Contention

Notably, HB 1265 has sparked debate regarding the ethical and practical implications of mandating such coverage. Proponents argue that this bill supports individuals who may later regret their gender transition and seek to reverse their treatment, thereby protecting their rights and welfare. However, opponents contend that the bill undermines healthcare autonomy and could dissuade individuals from pursuing necessary treatments due to concerns over future obligations for reversal coverage. Additionally, the broader implications for workplace practices and employer liability remain points of contention in the discussions surrounding the bill.